#Liver Meeting 2014

Click Here for More Conferences

Click Here for AASLD.org

An Introduction to Hepatitis

Click Here for More Conferences

Click Here for AASLD.org

An Introduction to Hepatitis

Viread Effectively Combats Hepatitis B for at Least 8 Years

Viread (tenofovir) is highly effective at suppressing hepatitis B, even after an eight-year period.

Lower Hep C Risk for Young IDUs on Opioid Maintenance Therapy

Taking opioid maintenance therapy with methadone or buprenorphine is linked to a 61 percent reduced risk of hepatitis C virus (HCV) among youn...

Gilead’s 8-Week Hep C Cure Is Good for Genotype 3, Not 1 or 2

Eight weeks of Sovaldi and GS-5816, with or without ribavirin, cured high rates of people with genotype 3 of hepatitis C, but yielded unsatisf...

Harvoni Cures High Rates of People With Genotype 4 of Hep C

Gilead Sciences’ newly approved Harvoni (ledipasvir/sofosbuvir) cured nearly all people with genotype 4 of hepatitis C in a small trial.

Sovaldi-Based Hep C Regimens Work Well in the Real World

Hepatitis C treatments based on Gilead Sciences’ Sovaldi (sofosbuvir) are faring just as well in the real world as in clinical trials.

AbbVie’s ’3D’ Regimen Plus Ribavirin Cures All With Hep C Genotype 4

AbbVie’s ’3D’ regimen plus ribavirin cured all people with genotype 4 of hepatitis C in a recent trial, plus 91 percent of those with genotype...

MUST read

Hepatitis C: The Basics

Hepatitis B: The Basics

Hepatitis A: The Basics

Interferon Raises Chance of HBsAg Loss in People With Hepatitis B

Adding interferon to Viread (tenofovir) treatment for hepatitis B virus raised the likelihood of hep B surface antigen (HBsAg) loss in an ongo...

Harvoni Cures Almost All People With Hep C Coinfected With HIV

Twelve weeks of Gilead Sciences newly approved Harvoni cured nearly all people with genotype 1 of hepatitis C who were coinfected with HIV in...

Sovaldi and Olysio Cure High Rates of Hep C Post-Liver Transplant

Sovaldi (sofosbuvir) and Olysio (simeprevir), with or without ribavirin, cures over 90 percent of people with hepatitis C who have had a liver...

12 Weeks of Harvoni and Ribavirin Cures 96% of Cirrhotics With HCV

Twelve weeks of Harvoni plus ribavirin cured nearly all highly treatment-experienced cirrhotic people with genotype 1 of hepatitis C virus.

High Post-Liver Transplant Survival Rates for People With HIV

HIV-positive people who have liver transplants because of liver cancer have high survival rates.

#Liver Meeting 2014

Click Here for More Conferences

Click Here for AASLD.org

An Introduction to Hepatitis

Click Here for More Conferences

Click Here for AASLD.org

An Introduction to Hepatitis

Viread Effectively Combats Hepatitis B for at Least 8 Years

Lower Hep C Risk for Young IDUs on Opioid Maintenance Therapy

Gilead’s 8-Week Hep C Cure Is Good for Genotype 3, Not 1 or 2

Harvoni Cures High Rates of People With Genotype 4 of Hep C

Sovaldi-Based Hep C Regimens Work Well in the Real World

AbbVie’s ’3D’ Regimen Plus Ribavirin Cures All With Hep C Genotype 4

MUST read

Hepatitis C: The Basics

Hepatitis B: The Basics

Hepatitis A: The Basics

Interferon Raises Chance of HBsAg Loss in People With Hepatitis B

Harvoni Cures Almost All People With Hep C Coinfected With HIV

Sovaldi and Olysio Cure High Rates of Hep C Post-Liver Transplant

12 Weeks of Harvoni and Ribavirin Cures 96% of Cirrhotics With HCV

High Post-Liver Transplant Survival Rates for People With HIV

Hot topics

Forums: Support and discussion

Blogs: The community speaks

Harvoni Posts Good Cure Rates for Hepatitis Genotypes 3 and 6

U.S. Vets Have Low Rates of Hep B Testing and Treatment

Excellent Results for 12 and 18 Weeks of Merck’s Dual Hep C Regimen

4 Weeks of Merck’s Hep C Meds Plus Sovaldi Fails; 8 Weeks Does Well

ACH-3102 Plus Sovaldi Cures 100% of Genotype 1 in 8 Weeks

Science News

Newsfeed

Features

Ask Hep